Company Filing History:
Years Active: 2022-2025
Title: Pål Stenmark: Innovator in Therapeutic Compounds
Introduction
Pål Stenmark is a notable inventor based in Järfälla, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. With a total of 2 patents, his work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Stenmark's latest patents include the development of 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives. These compounds are recognized for their potential use in therapy, specifically for the treatment of cancers, inflammation, autoimmune diseases, and graft-versus-host diseases, particularly in transplantation patients. His patents also detail a pharmaceutical composition comprising these compounds or their salts, along with methods for preparing them.
Career Highlights
Pål Stenmark is associated with the Thomas Helledays Stiftelse for Medicinsk Forskning, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on therapeutic practices.
Collaborations
Stenmark collaborates with esteemed colleagues, including Christoffer Bengtsson and Sanjay Borhade, contributing to a dynamic research environment focused on innovative medical solutions.
Conclusion
Pål Stenmark's contributions to the field of therapeutic compounds highlight his role as an influential inventor. His ongoing research and patents reflect a commitment to improving treatment options for serious medical conditions.